Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
NCT05739851
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
DA-1229_01 2.5/500mg (Before)
DRUG:
DA-1229_01 2.5/500mg (After)
Sponsor
Dong-A ST Co., Ltd.